21 May 2009
Hemolytic uremic syndrome (HUS)/thrombotic microangiopathy (TMA) in renal allograft recipients-prognostic factors
O Kozińska-Przybył, A Mróz, Z Lewandowski, A Chmura, Z Gałązka, M DurlikAnn Transplant 2009; 14(1): 26-26 :: ID: 880292
Abstract
Material/Methods: 74 cases of TMA were identified from the histopathology database of Department of Transplantation Medicine and Nephrology in Warsaw (Poland). Archived renal biopsy specimen and accompanying medical records for each patient were obtained and reviewed. Patients were divided into 2 groups: A (n=32) who developed HUS until 1 month post-transplant and B (n=42) who developed TMA later. Data extracted from each clinical record included: HLA histocompatibility, CIT,treatment of HUS/TMA, infections, type of immunosuppressant drugs. Data extracted from biopsy specimen included: presence of C4D deposits, PTC infl ammatory infiltrates, necrosis of vascular wall, presence of clotting, tubulitis, chronic vascular, glomerular and interstitial changes and interstitial inflammatory infiltrates. Cox Model was used and HR was estimated. End point was time of returning on haemodialysis.
Results: Patients from group A became dialysis dependent later compared to group B (observation time 108 months, HR=0.33; p<0.001). After 70 months of
observation 73% of patients from group B returned on dialysis and 33 % of
group A. Risk factors of returning on dialysis despite the time of developing HUS/TMA were: presence of clotting (HR=3.076; p<0.01), necrosis of vascular wall (HR 3.921; p<0.0359), tubulitis (HR 2,.373; p<0.0492), PTC inflammatory infiltrates (HR 5.467; p<0.0273). No correlation with C4D deposits was found.
Conclusions: Negative prognostic factors might be connected with coexistence of acute interstitial and/or vascular rejection in a renal biopsy specimen. It can be assumed that histopathology findings usually considered associated with acute rejection should prompt additional clinical management. On the other hand C4D deposits seem not to be sufficient to unequivocally diagnose acute rejection as factor C4D did not differentiate our patients. Further investigation is mandatory.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






